相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An algorithm for optimal testing in co-segregation analysis
Ronald W. Buie et al.
HUMAN MUTATION (2022)
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
Masayuki Sekine et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
Maiko Okano et al.
JOURNAL OF HUMAN GENETICS (2021)
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance
Marcy E. Richardson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation
Alvaro N. Monteiro et al.
JOURNAL OF MEDICAL GENETICS (2020)
High-throughput functional evaluation of BRCA2 variants of unknown significance
Masachika Ikegami et al.
NATURE COMMUNICATIONS (2020)
Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predisposition
Simona Agata et al.
SCIENTIFIC REPORTS (2020)
Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients
Minako Mori et al.
HAEMATOLOGICA (2019)
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T. Parsons et al.
HUMAN MUTATION (2019)
Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X
Reiko Yoshida et al.
Oncotarget (2019)
State-of-the-art strategies for targeting the DNA damage response in cancer
Patrick G. Pilie et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
CADD: predicting the deleteriousness of variants throughout the human genome
Philipp Rentzsch et al.
NUCLEIC ACIDS RESEARCH (2019)
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Sarah E. Brnich et al.
GENOME MEDICINE (2019)
A comparison of cosegregation analysis methods for the clinical setting
John Michael O. Ranola et al.
FAMILIAL CANCER (2018)
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
Masami Arai et al.
JOURNAL OF HUMAN GENETICS (2018)
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches
Lucia Guidugli et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Sean V. Tavtigian et al.
GENETICS IN MEDICINE (2018)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Yukihide Momozawa et al.
NATURE COMMUNICATIONS (2018)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
SIFT missense predictions for genomes
Robert Vaser et al.
NATURE PROTOCOLS (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Timothy R. Rebbeck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The MEME Suite
Timothy L. Bailey et al.
NUCLEIC ACIDS RESEARCH (2015)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Amanda B. Spurdle et al.
BREAST CANCER RESEARCH (2014)
A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity
Lucia Guidugli et al.
CANCER RESEARCH (2013)
A Review of a Multifactorial Probability-Based Model for Classification of BRCA1 and BRCA2 Variants of Uncertain Significance (VUS)
Noralane M. Lindor et al.
HUMAN MUTATION (2012)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
Kokichi Sugano et al.
CANCER SCIENCE (2008)
Classification of Rare Missense Substitutions, Using Risk Surfaces, With Genetic- and Molecular-Epidemiology Applications
Sean V. Tavtigian et al.
HUMAN MUTATION (2008)
Sequence Variant Classification and Reporting: Recommendations for Improving the Interpretation of Cancer Susceptibility Genetic Test Results
Sharon E. Plon et al.
HUMAN MUTATION (2008)
Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2:: A survey of genetic counseling practice
N Petrucelli et al.
GENETIC TESTING (2002)
分享论文
